Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
535.00    5.00 (0.94%)
Bid:
530.00
Ask:
540.00
Spread: 10.00 (1.887%)
Market Cap: £87.54m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Final Results

11 Feb 2008 07:00

Anglo Platinum Limited11 February 2008 ANGLO PLATINUM RESULTS FOR THE YEAR ENDED 31 DECEMBER 2007 Anglo Platinum is pleased to announce record headline earnings for the yearended 31 December 2007. Headline earnings and headline earnings attributable toordinary shareholders increased to R12.3 billion with headline earnings perordinary share decreasing 3% to R52.39 as a result of an increased weightedaverage number of shares in issue in 2007. The primary factors contributing tothe increased earnings were higher US dollar prices realised on metals soldoffset by lower sales volumes on the back of reduced production from miningoperations. A final dividend of R23.00 per ordinary share has been declared,bringing the full-year dividend to R52.00 per share and maintaining a dividendcover ratio of 1. Joint acting CEO Norman Mbazima said, "Our record financial performance wasdriven by strong demand and record metal prices despite the tough operatingconditions. We are pleased with the progress made on implementing the MvelaResources and Anooraq Resources BEE transactions and our employee shareownership plan, all of which further enhance transformation of the South Africanmining sector and further progress our economic and social transformationobjectives." Platinum production from mining operations decreased by 6% to 2.47 millionounces in 2007 as a result of reduced labour efficiency and interventions aimedat achieving a significant improvement in employee safety. The reduction inrefined ounces, also to 2.47 million ounces, was a 12% decrease due to reducedmining output and movements in process pipeline stocks. Joint acting CEO Duncan Wanblad commented, "Anglo Platinum remains committed tothe principle of zero harm and we have implemented a major shift in our approachto safety. The creation of a culture in which safety standards are paramountremains our overriding priority and is at the heart of our new approach. Whileinterventions to achieve a significant improvement in employee safety, ashortage of skilled labour and the unsettled labour situation were the primaryreasons for lower production, we believe that the actions we have taken toaddress these challenges are starting to take effect. " Anglo Platinum remains confident of continued robust demand for platinum and iscommitted to increasing production in line with growth in global demand. "It is pleasing that in 2007 our board approved new capital expenditure to thevalue of R10.7 billion in continued support of maintaining existing anddeveloping additional production capacity. In 2008, a further R5.9 billion toexpand output at our Twickenham mine was approved," said Duncan. "The challengesencountered in 2007 have been compounded in 2008 by production disruptionsarising from constrained electricity supply by Eskom. We continue to engageEskom and the relevant Government departments directly and with the SouthAfrican mining industry to address the constraints in the most effectivemanner", he added. Anglo Platinum's commitment to employee safety, including the principle of zeroharm, will continue to be an area of focus in 2008. The new approach to safety,alongside the operational difficulties, has had a material impact in 2007, whichis likely to continue in 2008. Production disruptions arising from Eskom'sinability to supply sufficient power have been experienced in 2008. Consequentlyrefined platinum production is expected to be 2.4 million ounces. Johannesburg11 February 2008 For further information, please contactTrevor Raymond +27 (0) 11 373-6462, +27 (0) 82 654 8467 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Mar 20257:00 amRNSUpdate on Timing of Full Year Results Announcement
15th Jan 20257:00 amRNSGrant of options under SAYE Scheme
10th Jan 20257:00 amRNSFull year trading statement
9th Jan 20257:00 amRNSTotal Voting Rights
16th Dec 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
16th Dec 20247:00 amRNSLaunch of SAYE Scheme
29th Nov 20247:00 amRNSTotal Voting Rights
30th Sep 20247:00 amRNSAcquisition of Bio-Vet Inc.
13th Sep 20247:00 amRNSNotice of Investor Presentation
11th Sep 20247:00 amRNSInterim results
14th Aug 202411:22 amRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSBlock listing Interim Review
25th Jun 20242:34 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Statement
12th Jun 20244:11 pmRNSHolding(s) in Company
24th May 202410:04 amRNSPosting of Annual Report and Notice of AGM
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.